Cytokinetics Inc. buy Stifel Nicolaus
Start price
22.01.25
/
50%
€45.00
Target price
22.01.26
€76.65
Performance (%)
-4.89%
Price
02.09.25
€42.80
Summary
This prediction is currently active. With a performance of -4.89%, the BUY prediction for Cytokinetics Inc. by Stifel_Nicolaus is down slightly. This prediction currently runs until 22.01.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 29.697% | 29.697% |
| iShares Core DAX® | -2.458% | 0.524% |
| iShares Nasdaq 100 | -1.226% | 1.491% |
| iShares Nikkei 225® | -1.984% | 3.351% |
| iShares S&P 500 | -0.767% | 2.346% |
Comments by Stifel_Nicolaus for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $80.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat